Abivax S.A. (ABVX)
Abivax S.A., operating as ABIVAX Société Anonyme, is a French pharmaceutical firm focused on the discovery and optimization of therapeutic drugs for inflammatory, infectious, and oncological diseases. A cornerstone of their product pipeline is ABX464, which is currently undergoing Phase IIb clinical trials for ulcerative colitis, Crohn's Disease, and COVID-19. This compound is also being evaluated in Phase IIa studies for rheumatoid arthritis and has successfully completed Phase IIa trials demonstrating viral remission in patients with HIV. Additionally, the company is advancing ABX 196, an immune-boosting candidate, through Phase 1/2 clinical trials targeting hepatocellular cancer. Abivax also conducts research initiatives for conditions like Dengue fever, influenza, and respiratory syncytial virus. The company has secured license agreements with key French scientific bodies, including the National Centre for Scientific Research, the University of Montpellier, and the Institut Curie. Founded in 2013, Abivax S.A. maintains its headquarters in Paris, France.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Abivax S.A.
NASDAQ:ABVXHealthcare · Biotechnology
-2.77%$86.59
AH$87.03+0.51%vs close
Mkt Cap$7.58B
Float77.44M
O/S87.54M
Vol
$ Vol
RVOL
Inst Own63.3%
SI9.4%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$375.49M
Total Assets$652.55M
Free Cash Flow-$174.09M
Debt & Equity
Debt 9%
Equity 91%
Total Debt$51.27M
Total Equity$508.34M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in ABVX's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$652.55M
Liabilities$144.21M
Accounts Receivable$11.72M
Accounts Payable$41.95M
Inventory$0
PP&E (Net)$2.33M
Goodwill$20.57M
Intangible Assets$7.38M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $70K | $2K | $20K | $11K | $142K | $47K | $16K | $83K |
| YoY Growth | - | - | - | - | - | 3050.0% | -88.9% | 80.0% | -92.1% | 202.4% | 200.0% | -81.1% | - |
| Cost of Revenue | $0 | $0 | $0 | $56.71M | $50.85M | $37.74M | $31.49M | $17.18M | $16.21M | $16.36M | $385K | $3.66M | $6.29M |
| Gross Profit | $0 | $0 | $0 | -$56.71M | -$50.85M | -$37.74M | -$31.49M | -$17.16M | -$16.2M | -$16.22M | -$339K | -$3.65M | -$6.21M |
| Gross Margin | - | - | - | - | - | -53623.8% | -1409300.0% | -85327.8% | -144970.0% | -11431.5% | -721.4% | -23321.4% | -7516.1% |
| Research and Development | $198.59M | $163.71M | $115.27M | $53.96M | $53.38M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Selling, General, and Administrative | $81.4M | $43.46M | $32.2M | $8.37M | $6.23M | $6.26M | $5.47M | $4.8M | $4.23M | $3.97M | $15.5M | $2.03M | $1.49M |
| Other | -$5.11M | -$13.91M | -$5.16M | -$46.61M | -$64.21M | -$1.54M | $244K | -$613K | -$4.61M | $179K | $0 | -$34K | $569K |
| Total Operating Expenses | $274.89M | $193.26M | $142.3M | $15.72M | -$4.6M | $4.72M | $5.71M | $4.19M | -$388K | $4.15M | $20.06M | $2M | $2.06M |
| Operating Income (EBIT) | -$274.89M | -$193.26M | -$142.3M | -$72.43M | -$46.25M | -$42.46M | -$37.2M | -$21.35M | -$15.81M | -$20.37M | -$20.39M | -$5.65M | -$8.26M |
| Operating Margin | - | - | - | - | - | -60330.2% | -1664800.0% | -106155.6% | -141500.0% | -14359.1% | -43464.3% | -36100.0% | -10003.6% |
| Interest Expense | $31.82M | $13.89M | $15.45M | $7.75M | $3.97M | $2.3M | $1.77M | $524K | $0 | $47K | $188K | $73K | $189K |
| Interest Income | $6.43M | $10.01M | $3.1M | $0 | $0 | $0 | $16K | $88K | $130K | $336K | $56K | $12K | $9K |
| Other Income (Expense) | -$94.07M | -$3.64M | -$22.75M | $4.58M | -$1.18M | -$44.83M | -$1.78M | -$768K | $86K | $288K | $0 | -$73K | -$180K |
| Income Before Tax (EBT) | -$368.96M | -$196.9M | -$165.06M | -$67.86M | -$47.43M | -$44.83M | -$38.98M | -$22.11M | -$15.72M | -$20.09M | -$20.53M | -$5.72M | -$8.44M |
| Income Tax Expense | $6.53M | $0 | $0 | $0 | $0 | -$2.88M | -$4.76M | -$4.44M | -$3.01M | -$3.93M | -$3.17M | -$870K | -$1.86M |
| Net Income | -$375.49M | -$196.9M | -$165.06M | -$67.86M | -$47.43M | -$41.95M | -$34.22M | -$17.68M | -$12.54M | -$15.98M | -$17.82M | -$5.68M | -$6.58M |
| Net Income Margin | - | - | - | - | - | -59604.8% | -1531700.0% | -87905.6% | -112230.0% | -11266.1% | -37985.7% | -36285.7% | -7970.2% |
| Supplementary Data | |||||||||||||
| EPS | -4.65 | -2.80 | -3.43 | -3.18 | -2.75 | -2.62 | -2.51 | -1.56 | -1.14 | -1.48 | -1.65 | -0.73 | -0.64 |
| Diluted EPS | -4.65 | -2.80 | -3.43 | -3.18 | -2.75 | -2.62 | -2.51 | -1.55 | -1.13 | -1.47 | -1.64 | -0.73 | -0.64 |
| Weighted Average OS | 69.53M | 63.05M | 43.07M | 19.09M | 15.46M | 14.31M | 12.18M | 10.18M | 9.87M | 9.65M | 9.65M | 9.27M | 9.27M |
| EBITDA | -$335.94M | -$181.78M | -$148.82M | -$59.56M | -$43.11M | -$42.45M | -$37.12M | -$21.48M | -$15.62M | -$19.95M | -$20.17M | -$5.55M | -$8.24M |
| EBITDA Margin | - | - | - | - | - | -60315.9% | -1661100.0% | -106816.7% | -139800.0% | -14063.8% | -42988.1% | -35514.3% | -9972.8% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Assets | |||||||||||||
| Current Assets | |||||||||||||
| Cash and Cash Equivalents | $576.99M | $161.12M | $281.47M | $30.11M | $67.81M | $32.73M | $10.91M | $8.93M | $2.1M | $8.87M | $28.07M | $1.36M | $3.25M |
| Short-Term Investments | $15.3M | $0 | $10.11M | $0 | $7K | $7K | $7K | $5.59M | $16.93M | $16.81M | $15.64M | $1.9M | $447K |
| Cash and Short-Term Investments | $592.29M | $161.12M | $291.58M | $30.11M | $67.82M | $32.74M | $10.92M | $14.53M | $19.03M | $25.68M | $43.71M | $3.27M | $3.7M |
| Accounts Receivable | $11.72M | $17.5M | $21.34M | $9.29M | $9.32M | $8.98M | $7.8M | $8.68M | $4.07M | $5.37M | $4.37M | $2.67M | $2.51M |
| Inventory | $0 | $0 | $0 | $0 | $4.47M | $0 | $1.29M | $0 | $222K | $58K | $131K | $0 | $0 |
| Other Current Assets | $0 | $0 | -$1K | $0 | $0 | $1K | $0 | $1K | $221K | $0 | $0 | $0 | $29K |
| Total Current Assets | $615.59M | $190.67M | $319.49M | $40.42M | $84.03M | $42.08M | $20.38M | $23.44M | $23.32M | $31.1M | $48.21M | $6.3M | $6.26M |
| Long-Term Assets | |||||||||||||
| Property, Plant & Equipment Net | $2.33M | $2.98M | $980K | $1.78M | $104K | $112K | $150K | $169K | $225K | $215K | $187K | $258K | $74K |
| Goodwill | $20.57M | $20.58M | $20.58M | $20.58M | $36.58M | $35.76M | $35.76M | $35.76M | $35.76M | $35.76M | $35.76M | $35.76M | $36.59M |
| Intangible Assets | $7.38M | $7.38M | $7.38M | $7.38M | -$723K | $109K | $95K | $0 | $0 | $0 | $2K | $4K | $0 |
| Long-Term Investments | $0 | $141K | $139K | $0 | $239K | $240K | $247K | -$4.57M | -$16.11M | -$16.46M | -$14.92M | -$1.81M | -$400K |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $1.16M | $0 | $16.93M | $17.09M | $15.96M | $1.9M | $0 |
| Other Long-Term Assets | $6.68M | $7.53M | $16.83M | $14.24M | $3.07M | $1.36M | $1K | $5.59M | $2K | $1K | $7K | $0 | $447K |
| Total Long-Term Assets | $36.96M | $38.61M | $45.91M | $43.98M | $39.27M | $37.57M | $37.41M | $36.95M | $36.8M | $36.6M | $36.99M | $36.11M | $36.71M |
| Other Assets | $0 | -$1K | $0 | $0 | $0 | $1K | $1K | $0 | $0 | -$1K | $1K | $0 | $0 |
| Total Assets | $652.55M | $229.28M | $365.39M | $84.4M | $122.03M | $79.65M | $57.79M | $60.38M | $60.12M | $67.7M | $85.21M | $42.42M | $42.97M |
| Liabilities | |||||||||||||
| Current Liabilities | |||||||||||||
| Accounts Payable | $41.95M | $48.96M | $52.76M | $17.29M | $20.73M | $19.45M | $11.78M | $7.43M | $4.71M | $2.87M | $3.14M | $1.17M | $1.74M |
| Short-Term Debt | $31.8M | $47.86M | $34.5M | $32.95M | $11.24M | $13K | $23.17M | $12.18M | $0 | $285K | $358K | $1K | $0 |
| Current Income Tax Payable | $0 | $5.26M | $2.66M | $96K | $98K | $258K | $2.06M | $2.03M | $1.23M | $1.09M | $1.02M | $941K | $622K |
| Current Unearned Revenue | $0 | $0 | $58K | $149K | $181K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | -$17.77M | $594K | $3.92M | $3.2M | -$430K | $0 | -$23.17M | -$12.18M | $4K | -$285K | -$359K | -$1K | $0 |
| Total Current Liabilities | $70.38M | $103.71M | $98.44M | $57.49M | $36.05M | $21.68M | $13.85M | $9.49M | $6.08M | $3.96M | $4.16M | $2.11M | $2.37M |
| Long-Term Liabilities | |||||||||||||
| Long-Term Debt | $33.77M | $58.27M | $29.74M | $9.26M | $44.98M | $37.96M | $23.17M | $12.18M | $0 | $353K | $34K | $1K | $2.59M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $6.6M | $4.76M | $2.47M | $3.36M | $3.67M | $2.82M |
| Long-Term Deferred Tax Liabilities | $6.53M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $32.92M | $20.35M | $18.05M | $8.68M | $11.58M | $10K | $6K | -$6.6M | -$4.54M | -$2.45M | -$2.49M | -$1.28M | -$2.82M |
| Total Long-Term Liabilities | $73.83M | $80.23M | $47.97M | $18.87M | $57.01M | $37.97M | $23.17M | $12.18M | $219K | $372K | $900K | $2.39M | $2.6M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $144.21M | $183.94M | $146.41M | $76.37M | $93.06M | $59.66M | $37.02M | $21.67M | $6.3M | $4.33M | $5.03M | $4.5M | $4.96M |
| Stockholders' Equity | |||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $41.63M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $877K | $707K | $703K | $249K | $188K | $160K | $136K | $114K | $111K | $108K | $108K | $77K | $0 |
| Retained Earnings | -$824.68M | -$490.32M | -$316.11M | -$160.33M | -$91.4M | -$41.95M | -$103.94M | -$69.71M | -$52.03M | -$39.5M | -$23.51M | -$5.69M | $0 |
| Comprehensive Income & Other | $2.58M | -$84K | $125K | $337K | $1K | -$41.63M | $0 | $316K | $283K | $259K | $193K | $0 | $0 |
| Other Stockholders' Equity | $1.33B | $534.95M | $534.39M | $168.11M | $120.19M | $61.79M | $124.57M | $108.31M | $105.75M | $102.75M | $103.58M | $43.52M | $38.01M |
| Total Equity | $508.34M | $45.34M | $218.98M | $8.03M | $28.97M | $20M | $20.77M | $38.72M | $53.83M | $63.36M | $80.18M | $37.91M | $38.01M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $652.55M | $229.28M | $365.39M | $84.4M | $122.03M | $79.65M | $57.79M | $60.38M | $60.12M | $67.7M | $85.21M | $42.42M | $42.97M |
| Supplementary Data | |||||||||||||
| Total Debt | $51.27M | $108.77M | $64.85M | $43.75M | $57.71M | $37.98M | $23.17M | $12.18M | $0 | $353K | $391K | $2.33M | $2.59M |
| Net Debt | -$525.73M | -$52.35M | -$216.62M | $13.64M | -$10.11M | $5.25M | $12.26M | $3.24M | -$2.1M | -$8.51M | -$27.62M | $971K | -$657K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Operating Activities | ||||||||||||
| Net Income | -$360.67M | -$196.9M | -$165.06M | -$67.86M | -$47.43M | -$42.46M | -$37.2M | -$21.35M | -$15.81M | -$20.37M | -$20.39M | -$5.65M |
| Depreciation & Amortization | $1.2M | $1.23M | $790K | $542K | $337K | $74K | $89K | $79K | $104K | -$39K | $152K | $55K |
| Deferred Income Tax | $0 | $0 | $8.86M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $0 | $22.59M | $9.14M | -$1.3M | $925K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Changes in Working Capital: | ||||||||||||
| Accounts Receivable | $7.56M | $5.13M | -$15.9M | $349K | -$2.21M | -$3K | $3.51M | $13K | $809K | -$665K | $1.7M | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$740K |
| Accounts Payable | $0 | -$3.85M | $35.48M | -$2.67M | $1.27M | $0 | $0 | $2.72M | $1.84M | $0 | $1.97M | $0 |
| Other Working Capital | -$3.64M | $308K | $4.18M | $83K | $188K | $10.8M | $4.32M | $2.53M | $3.5M | $3.7M | $1.85M | $2.66M |
| Total Working Capital Change | $3.92M | $1.59M | $23.76M | -$2.24M | -$746K | $10.8M | $7.83M | $5.26M | $6.15M | $2.84M | $3.75M | $1.92M |
| Other Non-Cash Items | $181.62M | -$645K | $10.78M | $10.6M | -$3.42M | -$1.73M | -$1.41M | -$309K | $118K | $139K | -$156K | -$20K |
| Net Cash from Operating | -$173.94M | -$172.13M | -$111.73M | -$60.26M | -$50.33M | -$33.32M | -$30.69M | -$16.31M | -$9.44M | -$17.44M | -$16.65M | -$3.69M |
| Investing Activities | ||||||||||||
| Capital Expenditures | -$152K | -$715K | -$297K | -$322K | -$53K | -$1M | -$1.05M | -$852K | -$1.09M | -$806K | -$1.15M | -$48K |
| Acquisitions | $0 | $0 | $0 | -$3.25M | -$2.43M | $688K | $722K | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$15.19M | $0 | -$10.45M | -$525K | -$10K | -$328K | $0 | $0 | -$201K | $0 | -$219K | $0 |
| Sales of Investments | $537K | $0 | $828K | $244K | $0 | -$688K | $0 | $13K | $45K | $0 | $2K | $0 |
| Other Investing Activities | $76K | $18.32M | -$1.81M | -$9.58M | -$4.47M | $689K | -$84K | $555K | $1.13M | $700K | $227K | $0 |
| Net Cash from Investing | -$14.73M | $17.61M | -$11.73M | -$13.44M | -$6.96M | -$642K | -$413K | -$284K | -$117K | -$105K | -$1.14M | -$48K |
| Financing Activities | ||||||||||||
| Debt Repaid | - | -$41.88M | -$17.03M | $10.85M | -$21.37M | -$26.29M | -$12.23M | -$11.37M | -$2.3M | -$32K | -$2.23M | $88K |
| Common Stock Issuance | $657.85M | $485K | $394.8M | $51.81M | $77.85M | $29.49M | $15.27M | $728K | $702K | $65K | $62.38M | $6.94M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$656K | -$10.85M | -$31.35M | -$4.97M | -$6.85M | $0 | $0 | $0 | -$95K | -$587K | -$6.38M | -$351K |
| Net Cash from Financing | $594.28M | $31.51M | $380.48M | $35.99M | $92.37M | $55.78M | $27.5M | $12.1M | $2.9M | -$489K | $58.24M | $6.64M |
| Forex Effect | $29.38M | $2.66M | -$5.67M | $0 | $0 | $0 | $0 | -$1K | $0 | $0 | $0 | $0 |
| Net Change in Cash | $434.99M | -$120.35M | $251.36M | -$37.71M | $35.08M | $21.82M | -$3.61M | -$4.5M | -$6.65M | -$18.03M | $40.45M | $3.22M |
| Supplementary Data | ||||||||||||
| Operating Cash Flow | -$173.94M | -$172.13M | -$111.73M | -$60.26M | -$50.33M | -$33.32M | -$30.69M | -$16.31M | -$9.44M | -$17.44M | -$16.65M | -$3.69M |
| Capital Expenditure | -$152K | -$718K | -$296K | -$361K | -$53K | -$1M | -$1.05M | -$852K | -$1.09M | -$806K | -$1.15M | -$48K |
| Free Cash Flow | -$174.09M | -$172.85M | -$112.03M | -$60.62M | -$50.38M | -$34.32M | -$31.74M | -$17.17M | -$10.53M | -$18.24M | -$17.8M | -$3.74M |
| Cash at Beginning | $142M | $281.47M | $30.11M | $67.82M | $32.74M | $10.92M | $14.53M | $19.03M | $25.68M | $43.71M | $3.26M | $45K |
| Cash at End | $576.99M | $161.12M | $281.47M | $30.11M | $67.82M | $32.74M | $10.92M | $14.53M | $19.03M | $25.68M | $43.71M | $3.26M |